Skip to main content

Table 1 Baseline features of 31 participants and characteristics of the tumor and treatment with106Ru brachytherapy

From: Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography

Features

 

Mean Age (median, range-Y)

51 (55, 22–74)

Sex (F)

18 (56.8%)

Mean BCVA (median, range-LogMAR)

0.71 (0.52, 0.00–3.00)

Involved eye (OD)

20 (62.5%)

Mean distance to fovea (median, range-mm)

3.53 (3.00, 2.00–12.00)

Mean distance to optic disc (median, range-mm)

3.81 (3.00, 0.00–12.00)

Mean largest tumor diameter (median, range-mm)

14.08 (14.00,8.50–21.00)

Mean thickness (median, range-mm)

6.75 (6.70, 2.84–10)

Mean foveal dose (median, range-Gy)

45.76 (11.00, 0.00–501)

Mean optic disc dose (median, range-Gy)

32.91 (13.50, 0.00–266)

Mean apex dose (median, range-Gy)

84.29 (85, 40–100)